KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Equity Average (2019 - 2021)

BioNTech SE's Equity Average history spans 3 years, with the latest figure at $7.6 billion for Q4 2021.

  • For Q4 2021, Equity Average rose 598.57% year-over-year to $7.6 billion; the TTM value through Dec 2021 reached $7.6 billion, up 598.57%, while the annual FY2021 figure was $7.6 billion, 598.57% up from the prior year.
  • Equity Average for Q4 2021 was $7.6 billion at BioNTech SE, up from $1.1 billion in the prior quarter.
  • Across five years, Equity Average topped out at $7.6 billion in Q4 2021 and bottomed at $425.5 million in Q4 2019.
  • The 3-year median for Equity Average is $1.1 billion (2020), against an average of $3.0 billion.
  • The largest annual shift saw Equity Average surged 156.38% in 2020 before it surged 598.57% in 2021.
  • A 3-year view of Equity Average shows it stood at $425.5 million in 2019, then soared by 156.38% to $1.1 billion in 2020, then soared by 598.57% to $7.6 billion in 2021.
  • Per Business Quant, the three most recent readings for BNTX's Equity Average are $7.6 billion (Q4 2021), $1.1 billion (Q4 2020), and $425.5 million (Q4 2019).